Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Приобретенная чистая красноклеточная аплазия (эритробластопения)

Список литературы

  1. Means R.T. Pure red cell aplasia // Blood. 2016. Vol. 128, № 21.
  2. Means R.T. Pure red cell aplasia: The second hundred years // American Journal of the Medical Sciences. 2023. Vol. 366, № 3.
  3. Narla A., Lipton J.M., Means R.T. Red cell aplasia: Acquired and congenital disorders // Wintrobe’s Clinical Hematology: Fourteenth Edition. 2018.
  4. Ruggero D., Shimamura A. Marrow failure: A window into ribosome biology // Blood. 2014. Vol. 124, № 18.
  5. Frickhofen N. et al. Parvovirus B19 as a cause of acquired chronic pure red cell aplasia // Br J Haematol. 1994. Vol. 87, № 4.
  6. Brown K.E. et al. Resistance to Parvovirus B19 Infection Due to Lack of Virus Receptor (Erythrocyte P Antigen) // New England Journal of Medicine. 1994. Vol. 330, № 17.
  7. Жукова Л.Ю. Х.А.В., К.О.Л., С.Н.Е., Т.А.Н. Транзиторная эритробластопения детского возраста: обзор 39 случаев // Педиатр. 2015. Vol. 6, № 15. P. 44–53.
  8. Sawada K., Fujishima N., Hirokawa M. Acquired pure red cell aplasia: Updated review of treatment // British Journal of Haematology. 2008. Vol. 142, № 4.
  9. Gurnari C., Maciejewski J.P. How I manage acquired pure red cell aplasia in adults // Blood. 2021. Vol. 137, № 15.
  10. Lobbes H. et al. Pure red cell aplasia in systemic lupus erythematosus, a nationwide retrospective cohort and review of the literature // Rheumatology (United Kingdom). 2022. Vol. 61, № 1.
  11. Aung F.M. et al. Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation // Br J Haematol. 2013. Vol. 160, № 6.
  12. Masuda M. et al. Clonal T cells of pure red-cell aplasia // Am J Hematol. 2005. Vol. 79, № 4.
  13. Visco C. et al. Autoimmune cytopenias in chronic lymphocytic leukemia // American Journal of Hematology. 2014. Vol. 89, № 11.
  14. Fujishima N. et al. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: A Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group // Haematologica. 2008. Vol. 93, № 10.
  15. Mijovic A. et al. Chronic myeloid leukemia associated with pure red cell aplasia and terminating in promyelocytic transformation // Am J Hematol. 1989. Vol. 31, № 2.
  16. Bernard C. et al. Thymoma associated with autoimmune diseases: 85 cases and literature review // Autoimmunity Reviews. 2016. Vol. 15, № 1.
  17. Carson K.R. et al. Clinical characteristics of erythropoietin-associated pure red cell aplasia // Best Practice and Research: Clinical Haematology. 2005. Vol. 18, № 3 SPEC. ISS.
  18. Choudry M.A., Moffett B.K., Laber D.A. Pure red-cell aplasia secondary to pregnancy, characterization of a syndrome // Ann Hematol. 2007. Vol. 86, № 4.
  19. Nakazawa H. et al. Incidence of acquired pure red cell aplasia: a nationwide epidemiologic analysis with 2 registry databases in Japan // Blood Adv. 2022. Vol. 6, № 24.
  20. Balasubramanian S.K. et al. Rational management approach to pure red cell aplasia // Haematologica. 2018. Vol. 103, № 2.
  21. Masaoka A. et al. Thymomas associated with pure red cell aplasia. Histologic and follow‐up studies // Cancer. 1989. Vol. 64, № 9.
  22. Seifi S. et al. Thymoma recurrence and its predisposing factors in Iranian population: A single center study // Tanaffos. 2019. Vol. 18, № 4.
  23. Hishida T. et al. Clinical features and prognostic impact of coexisting autoimmune disease other than myasthenia gravis in resected thymomas: Analysis of a Japanese multi-institutional retrospective database // European Journal of Cardio-thoracic Surgery. 2021. Vol. 59, № 3.
  24. Maggi G. et al. Thymoma: Results of 241 operated cases // The Annals of Thoracic Surgery. 1991. Vol. 51, № 1.
  25. Qiu Z.Y. et al. Methotrexate therapy of T-cell large granular lymphocytic leukemia impact of STAT3 mutation // Oncotarget. 2016. Vol. 7, № 38.
  26. Kawahara S. et al. Clinical analysis of 52 patients with granular lymphocyte proliferative disorder (GLPD) showed frequent anemia in indolent T-cell GLPD in Japan // Eur J Haematol. 2009. Vol. 82, № 4.
  27. Kwong Y.L. et al. T-cell large granular lymphocyte leukemia: An Asian perspective // Annals of Hematology. 2010. Vol. 89, № 4.
  28. Hampel P.J. et al. Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre // Br J Haematol. 2018. Vol. 183, № 3.
  29. Tsang M. et al. Pure Red Cell Aplasia (PRCA) in Chronic Lymphocytic Leukemia (CLL): Etiology, Therapy, and Outcomes // Blood. 2015. Vol. 126, № 23.
  30. Longval T. et al. Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study // Br J Haematol. 2021. Vol. 193, № 4.
  31. World Health Organization. ICD-10: international statistical classification of diseases and related health problems: tenth revision. 2nd ed. Geneva PP  - Geneva: World Health Organization.
  32. Petrenko A.A. et al. Pure red cell aplasia of the bone marrow in combination with thymoma. A literature review and own data // Ter Arkh. 2019. Vol. 91, № 7.
  33. Shimizu R. et al. Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation // Annals of Hematology. 2019. Vol. 98, № 7.
  34. Hevessy Z. et al. Algorithm of differential diagnosis of anemia involving laboratory medicine specialists to advance diagnostic excellence // Clin Chem Lab Med. 2024. Vol. 62, № 3.
  35. Soma P., Ellemdin S., Mashoeshoe K.S. The differential diagnosis of HIV related anaemia should include pure red cell aplasia // HIV and AIDS Review. 2013. Vol. 12, № 4.
  36. Teague D. et al. Hepatitis C Infection Associated with Acquired Pure Red Cell Aplasia // Trop Med Infect Dis. 2023. Vol. 8, № 1.
  37. Fu R. et al. The clinical characteristics and therapy response of patients with acquired pure red cell aplasia // Hematology. 2018. Vol. 23, № 9.
  38. Pivnik A. V. et al. Pure red cell aplasia with M-gradient: A literature review and clinical experience // Klinicheskaya Onkogematologiya/Clinical Oncohematology. 2018. Vol. 11, № 3.
  39. Zhu P. et al. Prevalence of Pure Red Cell Aplasia Following Major ABO-Incompatible Hematopoietic Stem Cell Transplantation // Front Immunol. 2022. Vol. 13.
  40. Shokrgozar N., Tamaddon G. ABO blood grouping mismatch in hematopoietic stem cell transplantation and clinical guides // International Journal of Hematology-Oncology and Stem Cell Research. 2018. Vol. 12, № 4.
  41. Charles R.J. et al. The pathophysiology of pure red cell aplasia: Implications for therapy // Blood. 1996. Vol. 87, № 11.
  42. Lacy M.Q., Kurtin P.J., Tefferi A. Pure red cell aplasia: Association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities // Blood. 1996. Vol. 87, № 7.
  43. Crabol Y. et al. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus B19 infection: A retrospective study of 10 patients and review of the literature // Clinical Infectious Diseases. 2013. Vol. 56, № 7.
  44. Thompson D.F., Gales M.A. Drug‐Induced Pure Red Cell Aplasia // Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 1996. Vol. 16, № 6.
  45. Mouthon L., Guillevin L., Tellier Z. Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia // Autoimmunity Reviews. 2005. Vol. 4, № 5.
  46. Kurhade K. et al. Multiple modalities in treating pediatric pure red cell aplasia: A case series // Pediatric Hematology Oncology Journal. 2023. Vol. 8, № 3.
  47. Lobbes H. et al. Treatment strategy for acquired pure red cell aplasia: a systematic review and meta-analysis // Blood Advances. 2023. Vol. 7, № 21.
  48. Biswal N., Narayanan P., Chetan G. Cyclosporine A responsive pure red cell aplasia in a child with systemic lupus erythematosus // Indian Journal of Hematology and Blood Transfusion. 2007. Vol. 23, № 3–4.
  49. Long Z. et al. Successful treatment of refractory/relapsed acquired pure red cell aplasia with sirolimus // Ann Hematol. 2018. Vol. 97, № 11.
  50. Huang Y. et al. Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial // Leukemia. 2022. Vol. 36, № 5.
  51. Yang Y. et al. Sirolimus versus cyclosporine A in patients with primary acquired pure red cell aplasia: a prospective cohort study // Blood Cancer Journal. 2023. Vol. 13, № 1.
  52. Salama Y. et al. Isolated anemia in patients with large granular lymphocytic leukemia (LGLL) // Blood Cancer J. 2022. Vol. 12, № 2.
  53. Ghazal H. Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia // Blood. 2002. Vol. 99, № 3.
  54. Khan F. et al. Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation // Transfusion Medicine. 2014. Vol. 24, № 3.
  55. Harris S.I., Weinberg J.B. Treatment of red cell aplasia with antithymocyte globulin: Repeated inductions of complete remissions in two patients // Am J Hematol. 1985. Vol. 20, № 2.
  56. Gomez-Arteaga A. et al. Use of anti-thymocyte globulin (ATG) for the treatment of pure red cell aplasia and immune-mediated cytopenias after allogeneic hematopoietic cell transplantation: a case series // Bone Marrow Transplantation. 2020. Vol. 55, № 12.
  57. Mangla A H.H. Pure red cell aplasia // Treasure Island, FL: FL: StatPearls Publishing. 2021.
  58. Passweg J.R., Rabusin M. Hematopoetic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias // Autoimmunity. 2008. Vol. 41, № 8.
  59. Halkes C. et al. Allogeneic stem cell transplantation for acquired pure red cell aplasia // American Journal of Hematology. 2019. Vol. 94, № 11.
  60. Кузьмина Л. А. Петинати Н. А. Л.Л.С. и др. Применение избирательной сорбции изогемагглютининов альфа у больной парциальной красноклеточной аплазией после трансплантации аллогенного костного мозга // Гематология и трансфузиология. 2011. P. 40–44.
  61. Dellacasa C.M. et al. Efficacy of plasmapheresis for the treatment of pure red blood cell aplasia after allogeneic stem cell transplantation // Transfusion (Paris). 2015. Vol. 55, № 12.
  62. Zhidong W., Hongmin Y., Hengxiang W. Successful treatment of pure red cell aplasia with a single low dose of rituximab in two patients after major ABO incompatible peripheral blood allogeneic stem cell transplantation // Transfusion Medicine. 2012. Vol. 22, № 4.
  63. Busca A. et al. Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation // Biology of Blood and Marrow Transplantation. 2018. Vol. 24, № 8.
  64. Rautenberg C. et al. Daratumumab for treatment of pure red cell aplasia after allogeneic stem cell transplantation // Bone Marrow Transplantation. 2020. Vol. 55, № 6.
  65. Martino R., García-Cadenas I., Esquirol A. Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation // Bone Marrow Transplantation. 2022. Vol. 57, № 2.
  66. Verholen F. et al. Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion // Eur J Haematol. 2004. Vol. 73, № 6.
  67. Marco-Ayala J. et al. Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question // Bone Marrow Transplantation. 2021. Vol. 56, № 4.
  68. Thompson C.A., Steensma D.P. Pure red cell aplasia associated with thymoma: Clinical insights from a 50-year single-institution experience // Br J Haematol. 2006. Vol. 135, № 3.
  69. Yen C.C. et al. Pure Red Cell Aplasia and Other Haematological Diseases Associated With Thymoma: A Case Series and Systematic Review // Front Med (Lausanne). 2021. Vol. 8.
  70. Moriyama S. et al. Pure red cell aplasia associated with thymoma: A report of a single-center experience // J Thorac Dis. 2018. Vol. 10, № 8.
  71. Камельских Д. В К.М.Е. Подбор компонентов донорской крови в случае трансплантации аллогенного костного мозга и/или аллогенных гемопоэтических стволовых клеток // Гематология и трансфузиология. 2022. P. 112–113.
  72. Carreras E D.C.M.M.K.N. (editors). The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies, 7th edition. Cham (CH): Springer. 2019. 163–169 p. 

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*